Results per Page:
Overcoming immune evasion: a new combination therapy advances treatment for a rare metastatic eye cancer
From Dr. Shailender Bhatia, Dr. Natalie Miller and colleagues, Clinical Research Division
Dr. Shailender Bhatia receives the Lyn and Daniel Lerner Endowed Chair in Merkel Cell Carcinoma
A family’s generosity will fuel the search for new ways to treat an aggressive skin cancer
$5.25M from the Kuni Foundation propels innovative adult oncology research
Grants will support research on tumor regression, immunotherapy access and better care for breast, liver and peritoneal malignancies
Rethinking immunotherapy dosing frequency for better cost, time, and life savings!
From the Bhatia group, Clinical Research Division
Reducing frequency of immunotherapy dosing could save money and time, keep patients on therapy longer
Study of immune checkpoint inhibitor dosing in patients with advanced skin cancers could help guide long-term treatment plans
$12M NIH grant to study rare, aggressive skin cancer
Fred Hutch, UW researchers hope to improve immunotherapies for people with Merkel cell carcinoma
Immune booster may awaken body’s defenses against skin cancer
First-in-human pilot of experimental immunotherapy in Merkel cell carcinoma
New guide helps clinicians navigate immunotherapy revolution in Merkel cell carcinoma
‘Real-world’ review accompanies new clinical care guidelines in rare skin cancer
'Finally showing hope': Immunotherapy trial results transforming care for rare skin cancer
Immunotherapy trial results transforming care for rare skin cancer